Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein P17

Acta Virologica

Volumn 40, Issue 4, 1996, Pages 195-200

  Kageyama, S ^a   Katsumoto, T ^b   Taniguchi, K ^c,d   Ismail, S I ^c   Shimmen, T ^c,e   Sasao, F ^c   Gao, M ^c   Owatari, S ^c   Wakamiya, N ^c   Tsuchie, H ^c   Ueda, S ^c   Shiraki, K ^a   Kurimura, T ^c  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d EIKEN CHEMICAL CO LTD   (Japan)

^e SAWAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

human anti p17 antibody; human immunodeficiency virus type 1; matrix protein; neutralization; p17; vaccination

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PASSIVE IMMUNIZATION; VIRUS NEUTRALIZATION;

ANTIBODY SPECIFICITY; CARRIER STATE; CELL LINE, TRANSFORMED; GENE PRODUCTS, GAG; HIV ANTIBODIES; HIV ANTIGENS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; NEUTRALIZATION TESTS; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 16144364048     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bukrinsky M, Haggerty S, Dempsey M,Sharova N, Adzhubei A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M (1993): A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666-669.
2. Choudhury A, Yamada O, Wakamiya N, Kurimura T (1992): A prospective study on correlation between the disease in anti-p17 antibody level and progression to AIDS in asymptomatic carriers of HIV. Microbiol. Immunol. 36, 833-840.
3. Foley GE, Lazarus H, Farber S, Uzman G, Boone B, McCarthy R (1965): Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18, 522-529.
4. Graham B, Wright P (1965): Candidate AIDS vaccines. N. Engl. J. Med. 333, 1331-1339.
5. Henderson L, Bowers M, Sowder II, Serabyn S, Johnson D, Bess J Jr, Arthur L, Bryant D, Fenselau C (1992): Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: Posttranslational modifications, proteolytic processing, and complete amino acid sequences. J. Virol. 66, 1856-1865.
6. Ikuta K, Morita CX, Miyake S, Ito T, Okabayashi M, Sano K, Nakai M, Hirai K, Kato S (1989): Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly express HIV-1 antigens. Virology 170, 408-417.
7. Jiang J-D, Chu F-N, Naylor P, Kirkley J, Mandeli J, Wallace J, Sarin P, Goldstein A, Holland J, Bekesi J (1992): Specific antibody response to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection. J. Acquir. Immune D Syndr. 5, 382-390.
8. Kageyama S, Kurimura T (1990): Disappearance of anti-p17 correlates with successful isolation of human immunodeficiency virus and deterioration in clinical status. Int'l. J. STD & AIDS 1, 129-131.
9. Kahn J, Stites D, Scillian J, Murcar N, Stryker R, Volberding P, Naylor P, Goldstein A, Sarin P, Simmon V, Wang S-S, Haseltine P (1992): A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue subunit vaccine in seronegative subjects. AIDS Res. Hum. Retroviruses 8, 1321-1325.
10. Karageorgos L, Li P, Burrell C (1993): Characterization of HIV replication complex early after cell-to-cell infection. AIDS Res. Hum. Retroviruses 9, 817-823.
11. Katsumoto T, Asanaka M, Kageyama S, Kurimura T, Nakajima K, Noto A, Tanaka H, Sato R (1990): Budding processs and maturation of human immunodeficiency virus examined by means of pre-and post-embedding immunocolloidal gel electron microscopy. J. Electron Microsc. 39, 33-38.
12. Komiyama N, Hattori N, Inoue J-I, Sakuma S, Kurimura T, Yoshida M (1989): Nucleotide sequences of gag and env genes of a Japanese isolate of HIV-1 and their expression in bacteria. AIDS Res. Hum. Retroviruses 5, 411-419.
13. Lange J, de Wolf F, Krone W, Danner S, Coutinho R, Goudsmit J (1987): Decline of antibody reactivity of outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline. AIDS 1, 155-159.
14. Liu X, Ota A, Watanabe M, Ueda S, Saitoh A, Shinagawa H, Nakata A, Kurimura T, Wang X, Zhao Y, Kondo K, Seki J, Miyake S, Sakato N, Fujito H (1995): Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-l carrier sera. Microbiol. Immunol. 39, 775-785.
15. Matsushita S, Robert-Guroff M, Rusche J, Koito A, Hattori T, Hoshino H, Javaherian K, Takatsuki K, Putney S (1988): Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62, 2107-2114.
16. McNicholl J, McDougal J (1994): Immunologic escape as a mechanism of viral persistence in HIV-1 infection. Semin. Virol. 5, 307-317.
17. Miyoshi I, Taguchi H, Kubonishi I, Yoshimoto S, Ohtsuki Y, Shiraishi Y, Akagi T (1982): Type C virus-producing cell lines derived from adult T cell leukemia. Gann Monogr. Cancer Res. 28, 219-228.
18. 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30. Proc. Natl. Acad. Sci. USA 84, 2951-2955.
19. Papsidero L, Sheu M, Ruscetti F (1989): Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping. J. Virol. 63, 267-272.
20. Saito A, Tanaka N, Nakata A, Ikuta K, Shinagawa H (1992): A unique monoclonal antibody that recognize mature p17 of HIV but not its precursor. Microbiol. Immunol. 36, 105-111.
21. 1. Science 232, 1135-1137.
22. Shang F, Huang H, Revesz K, Chen H-C, Herz R, Pinter A (1991): Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: Identification of epitopes exposed at the surface of infected cells. J. Virol. 65, 4798-4804.
23. von Schwedler U, Kornbluth R, Trono D (1994): The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 6992-6996.
24. Weiss R (1993): How does HIV cause AIDS? Science 260, 1273-1279.